CTNM FY2026 earnings: results, stock reaction and implied move

Reported results

Cash, cash equivalents and marketable securities were $244.5 million as of September 30, 2026.
Research and development expenses were $16.0 million for the third quarter of 2026, a 45 percent increase from the third quarter of 2025.
General and administrative expenses were $5.0 million for the third quarter of 2026, a 26 percent increase from the third quarter of 2025.
Net loss was $18.7 million for the three months ended September 30, 2026, compared to $12.8 million for the third quarter of 2025.
Basic and diluted net loss per share was $0.49 for the three months ended September 30, 2026, compared to $0.45 for the three months ended September 30, 2025.

Contineum believes its cash resources are sufficient to fund its planned operations through mid-2029.

The figures above come from the earnings release the company filed with the SEC on 2026-11-03 (8-K, Item 2.02). Read the original filing on sec.gov.